SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Durect (DRRX)

Add DRRX Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 5/19/2017 9:29:58 AM - Followers: 80 - Board type: Free - Posts Today: 0

DURECT Corporation, a specialty pharmaceutical company, focuses on the development of pharmaceutical products for pain, central nervous system, disorders, cardiovascular disease, and other chronic diseases based on its proprietary drug formulations and delivery platform technologies. The company?s products include POSIDUR, a release formulation of bupivacaine under Phase IIb clinical trial, which is used for the treatment of post-surgical pain; and ELADUR, a transdermal bupivacaine patch under Phase IIb clinical trial that provides continuous delivery of bupivacaine for up to three days from a single application, as well as is used for the treatment of pain associated with post-herpetic neuralgia. It also offers Remoxy, an oral oxycodone gelatin capsule under development with pain therapeutics; and TRANSDUR-Sufentanil, a proprietary transdermal sufentanil patch under development, which provides continuous delivery of sufentanil for a period of up to seven days from a single application. In addition, the company offers CHRONOGESIC (sufentanil), a pain therapy system; and ALZET, the miniature implantable osmotic pumps and accessories for experimental research in mice, rats, and other laboratory animals, as well as conducts research and development of pharmaceutical products in collaboration with third party pharmaceutical and biotechnology companies. Further, it designs, develops, and manufactures various biodegradable polymers based on lactide, glycolide, and caprolactone under the LACTEL brand for pharmaceutical and medical device clients for use as raw materials in their products. The company has collaboration agreements with Alpharma Ireland Limited; Nycomed Danmark, APS; Pain Therapeutics, Inc.; Endo Pharmaceuticals Inc; Voyager Pharmaceutical Corporation; ALZA Corporation; EpiCept Corporation; and NeuroSystec Corporation. DURECT Corporation was founded in 1998 and is based in Cupertino, CA.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
DRRX News: Quarterly Report (10-q) 05/10/2017 04:47:35 PM
DRRX News: Current Report Filing (8-k) 05/10/2017 04:41:32 PM
DRRX News: DURECT Corporation Announces First Quarter 2017 Financial Results and Provides Corporate Update 05/10/2017 04:05:00 PM
DRRX News: Current Report Filing (8-k) 05/08/2017 07:17:29 AM
DRRX News: DURECT and Sandoz have Signed a $293 Million Development and Commercialization Agreement for POSIMIR® (SABER®-Bupivacaine) ... 05/08/2017 07:00:00 AM
#635   milestones Q2 closing deal - upfront payment to DURECT realfast95 05/19/17 09:29:58 AM
#634   the earnings call on this small Bio was realfast95 05/12/17 10:18:24 AM
#633   sha - BAM realfast95 05/11/17 03:02:08 PM
#632   DURECT Corporation Announces First Quarter 2017 Financial Results nlightn 05/10/17 04:15:05 PM
#631   Durect EPS in-line, beats on revenue nlightn 05/10/17 04:13:24 PM
#630   * * $DRRX Video Chart 05-08-17 * * ClayTrader 05/08/17 04:27:03 PM
#629   Also trading above top BB needs to come stock1ace1 05/08/17 01:23:57 PM
#628   Thats not 293 million upfront .. Read pr stock1ace1 05/08/17 09:52:06 AM
#627   $293M deal and last year revenue was $14M SchlumpyStock-Picker 05/08/17 09:18:42 AM
#626   DURECT and Sandoz have Signed a $293 Million ProfitScout 05/08/17 08:59:00 AM
#625   Durect, Novartis sign $293M U.S. development, marketing deal nlightn 05/08/17 08:16:50 AM
#624   Looking good pre market T695 05/08/17 07:51:37 AM
#623   DURECT Corporation Invites You to Join its First ProfitScout 05/04/17 05:04:34 PM
#622   now thats some very nice news ! this nlightn 04/27/17 10:39:10 PM
#621   The Life Sciences Report Examines How Trial Results ProfitScout 04/27/17 02:42:16 PM
#620   some big share blocks going through at the ask,... nlightn 04/26/17 10:33:07 AM
#619   additionally i'm not seeing any institutional or hedge nlightn 04/25/17 02:47:20 PM
#618   T695,.. it is definitely possible.,... .70,.... but their nlightn 04/25/17 02:36:15 PM
#617   Yea this one is definitely manipulated like crazy, T695 04/25/17 02:32:26 PM
#616   It may. These micro cap bio stocks are Woulfe 04/25/17 02:14:52 PM
#615   look like this could see .70 in no timev T695 04/25/17 02:11:47 PM
#614   DURECT Announces Presentation of Data from a Phase nlightn 04/24/17 04:18:42 PM
#613   DRRX avg dly vol 251k,....closing with 544k,...somethings up. nlightn 04/24/17 04:07:10 PM
#612   Probably be a delayed reaction run in the T695 04/24/17 03:45:34 PM
#611   DURECT Announces Presentation of Data from a Phase ProfitScout 04/24/17 09:22:40 AM
#610   Bounce coming!?!??!? T695 04/24/17 08:20:02 AM
#609   DURECT to Present Clinical Data at the International ProfitScout 04/17/17 09:30:17 AM
#608   .80's are coming. Good for new investors. But Valensio 04/13/17 01:36:37 PM
#607   Nice rise up in pps. Over $1 for Valensio 04/10/17 01:38:19 PM
#606   DURECT to Present at the H.C. Wainwright NASH ProfitScout 04/03/17 10:52:07 AM
#605   Life Sciences Report: torywhite2002 03/30/17 03:00:50 PM
#604   DURECT Corporation Announces Fourth Quarter and Full Year ProfitScout 03/15/17 09:40:04 AM
#603   coverage $3.00/Share by H.C. Wainwright realfast95 02/28/17 09:19:55 AM
#602   DURECT Corporation Invites You to Join its Fourth ProfitScout 02/24/17 05:25:25 PM
#601   DURECT Corporation Announces Update on DUR-928 Development Program ProfitScout 01/30/17 09:07:34 AM
#600   would like to see DRRX get back to blackbandit 12/21/16 01:42:35 PM
#599   Research Reports Coverage on Drug Makers Stocks -- ProfitScout 12/21/16 09:22:41 AM
#598   Feel the same way Youlie 12/08/16 04:24:52 PM
#597   judging by todays jump, looks like the data blackbandit 12/08/16 04:24:21 PM
#596   Yeah I think it's the acute function data Youlie 12/07/16 12:21:04 AM
#595   I believe it's going to be for nafld Youlie 12/07/16 12:18:54 AM
#594   expecting the additional nash data by years end blackbandit 12/07/16 12:15:12 AM
#593   Should go up soon. Haven't really looked for Youlie 11/26/16 12:36:20 AM
#592   I started to, but DRRX is already my blackbandit 11/25/16 10:38:53 PM
#591   I bought more today Youlie 11/25/16 10:33:10 PM
#590   read where DRRX got at least 3 upgrades blackbandit 11/25/16 10:29:50 PM
#589   they mentioned more results by end of this blackbandit 11/10/16 03:26:14 PM
#588   Results were great. Company hinted at spectacular results Youlie 11/01/16 10:21:15 AM
#587   Youlie, good call on timing of Nash data. blackbandit 11/01/16 10:19:20 AM
#586   $DRRX (+11.6% pre) DURECT Corp Tops Q3 EPS realfast95 11/01/16 08:35:31 AM